Névine Zariffa

Nov 1, 2024 | jitc.bmj.com | Hillary Andrews |Névine Zariffa |Katherine Nishimura |Emily Goren

Regular and Young Investigator Award AbstractsBiomarkers, Immune Monitoring and Novel Technologies 35 The impact of treatment modalities on use of ctDNA as an early endpoint in aNSCLC trials Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service.